Immuno Research Inc. (IRI) is looking for opportunities to work with researchers currently investigating the role of the immune system in disease and with an interest in investigating the potential impact of a panel of 5-6 novel beta glucans in modulating the immune system.
To facilitate this, IRI has developed a Research Grants Program that provides seed funding of $25,000 each for pilot projects testing IRI’s immune modulating compounds in established research models in areas of that are of interest to the company.
Our areas of interest include:
- Bacterial infections with particular interest in antibiotic resistance, tropical and neglected disease, tuberculosis and other respiratory infections and biodefense.
- Viral infections with particular interest in viral reservoirs/latent infections.
- Rheumatoid Arthritis and other immune/inflammatory disease such as Systemic Lupus Erythematosus, Irritable Bowel Disease, Crohn’s Disease, Ulcerative Colitis.
- Neuroinflammatory disease such as Multiple Sclerosis, Alzheimer’s Disease.
- Other areas, including Fibrosis, Diabetes, Atherosclerosis, Vaccine Adjuvants and Orphan diseases, that have an (innate) immune component.
There is a simple two-step process for application:
Step 1: Send or email a short grant request to:
Dr. Myra Patchen, Chief Scientific Officer
Immuno Research Inc.
3388 Mike Collins Drive, Suite B
Eagan Minnesota 55121
In the grant request, provide information on the researcher, overview of the research area and the research model to be used. Attach any relevant papers.
IRI’s review committee meets every other month to review grant requests. If interested, IRI may contact the researcher for a follow-up telephone call to discuss the model.
Step 2: After review, if there is interest from IRI, applicant will be asked to submit a short Grant Application that provides more a detailed research protocol and other required information.